FIGO recognises the urgent need for safe and effective preventive measures against epithelial ovarian cancer—one of the most ...

This year’s theme focuses on Menopause and Menopause Hormone Therapy (MHT), also known as Hormone Replacement Therapy (HRT), ...

We are delighted to celebrate that the EngenderHealth-led consortium FIGO is part of has been awarded a $89 million USAID ...

As FIGO president from 1991 to 1994 and editor of the International Journal of Gynecology and Obstetrics (IJGO) from 1985 to ...

The International Journal of Gynecology & Obstetrics (IJGO) has published the compelling new editorial ‘Beyond borders: The ...

FIGO regularly issues statements and joint statements.

We look back an extraordinary week of sharing and learning and building alliances to shape a better future for women and girls worldwide, and delve deeper into key themes of the Congress Scientific ...

Cervical cancer is the fourth most common cancer among women globally and ranks as the second most prevalent cancer in many low- and middle-income countries (LMICs). Importantly, this disease is both ...

We are excited to announce the launch of FIGO’s 2024-2025 webinar series. FIGO’s webinar series aims to bring together the global community of women’s health experts, advocates, early career ...